XML 75 R65.htm IDEA: XBRL DOCUMENT v3.19.2
Share-Based Compensation and Capital Stock - Summary of Change in Stock-Based Award Activity (Details)
6 Months Ended
Jun. 30, 2019
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 1,186,180
Granted (in shares) | shares 141,827
Exercised/Vested (in shares) | shares (350,618)
Expired (in shares) | shares 0
Forfeited (in shares) | shares (3,493)
Outstanding, ending balance (in shares) | shares 973,896
Options exercisable, ending balance (in shares) | shares 607,256
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Beginning balance - weighted average exercise price (in dollars per share) | $ / shares $ 54.13
Granted - Weighted average exercise price (in dollars per share) | $ / shares 81.15
Exercised/Vested - Weighted average exercise price (in dollars per share) | $ / shares 46.41
Expired - Weighted average exercise price (in dollars per share) | $ / shares 0
Forfeited - Weighted average exercise price (in dollars per share) | $ / shares 51.49
Ending balance - weighted average exercise price (in dollars per share) | $ / shares 60.86
Options Exercisable, ending balance - Weighted average exercise price (in dollars per share) | $ / shares $ 54.84
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Roll Forward]  
Weighted Average Remaining Contractual Term - Outstanding, ending balance 3 years 10 months 24 days
Weighted Average Remaining Contractual Term - Options Exercisable, ending balance 3 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Performance-Based Leveraging - Weighted average grant date fair value (in dollars per share) | $ / shares $ 51.49
Restricted stock  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 303,765
Granted (in shares) | shares 152,721
Exercised/Vested (in shares) | shares (98,609)
Forfeited (in shares) | shares (16,180)
Outstanding, ending balance (in shares) | shares 341,697
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 65.06
Granted - Weighted average grant date fair value (in dollars per share) | $ / shares 81.13
Exercised/Vested - Weighted average grant date fair value (in dollars per share) | $ / shares 61.95
Forfeited - Weighted average grant date fair value (in dollars per share) | $ / shares 71.31
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 72.84
Performance Vested Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 336,820
Granted (in shares) | shares 83,934
Performance-Based Leveraging (in shares) | shares 1,583
Exercised/Vested (in shares) | shares (73,242)
Forfeited (in shares) | shares (11,272)
Outstanding, ending balance (in shares) | shares 337,823
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 63.28
Granted - Weighted average grant date fair value (in dollars per share) | $ / shares 81.15
Exercised/Vested - Weighted average grant date fair value (in dollars per share) | $ / shares 50.69
Forfeited - Weighted average grant date fair value (in dollars per share) | $ / shares 73.69
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 70.05